(Q24201067)

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Trichuris suis therapy in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Traditional corticosteroids for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Immunologic profiles of persons recruited for a randomized, placebo-controlled clinical trial of hookworm infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Methotrexate for induction of remission in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Helminth therapy (worms) for allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Does the failure to acquire helminthic parasites predispose to Crohn's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Exposure to schistosome eggs protects mice from TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Helminths as governors of immune-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Experimental hookworm infection: a randomized placebo-controlled trial in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Aminosalicylates for induction of remission or response in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Helminth infection protects mice from anaphylaxis via IL-10-producing B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Methotrexate for induction of remission in refractory Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Budesonide for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

Examining the minimum important difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

7 January 2021

Hymenolepis diminuta: intestinal goblet cell response to infection in male C57 mice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

7 January 2021

Intestinal Helminths Protect in a Murine Model of Asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

7 January 2021

Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009400.PUB2

7 January 2021

10.1002/14651858.CD009400.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24442917

1 reference

Consolidated OpenCitations Corpus – April 2017